Dartmouth SYNERGY has received a $3.2 million National Institutes of Health (NIH) grant that will help speed research and clinical trials of promising treatments at academic medical centers across the nation.
Post Tagged with: "research"
Lilian Kabeche, a postdoctoral researcher in genetics at Dartmouth’s Norris Cotton Cancer Center and a recent Geisel PhD graduate, received the American Society for Cell Biology (ASCB) Beckman Coulter Distinguished Graduate Student Achievement Prize.
While deploying old-school Palm Pilots during a psychopathology research project, Dror Ben-Zeev, PhD made a surprising discovery that has led to innovative smartphone-based treatments for people with mental health issues.
Geisel School of Medicine graduate student Ruth Kabeche has been awarded the American Society for Microbiology’s Robert D. Watkins Graduate Research Fellowship.
A new article published by Geisel psychiatry professor John Christopher shows that as psychologists increasingly cross international borders in response to world disasters, it is essential for them to be aware of their own cultural values, beliefs, and perceptions while interacting with people of other cultures.
People with severe mental illness such as schizophrenia, schizoaffective disorder or bipolar disorder use a popular social media website like YouTube to provide and receive naturally occurring peer support, Dartmouth researchers report in the journal PLOS ONE.
Geisel post-doctoral researcher Elaina M. Melton, PhD, has received a prestigious NIH fellowship for emerging scientists that will support her research on two cholesterol-related diseases, atherosclerosis and xanthomatosis.
Using quality improvement measures in eight of the 10 hospitals in the Northern New England Cardiovascular Disease Study Group, researchers have found a way to reduce kidney injury in patients undergoing a procedure with contrast dye.
From the litter box to the laboratory, a microscopic organism native to cats shows promise in treating cancer. Dartmouth researchers’ mutated strain of T. gondii reprograms the natural power of the immune system to kill cells.